Skip to main content
Clinical Trials/NCT01801839
NCT01801839
Completed
Not Applicable

Detection Of Monocytes/Macrophages Function And Tim-3 Expression In Septic Patients

Chinese PLA General Hospital1 site in 1 country1 target enrollmentAugust 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sepsis
Sponsor
Chinese PLA General Hospital
Enrollment
1
Locations
1
Primary Endpoint
systemic inflammatory response to infection with organ dysfunction, hypoperfusion, or hypotension
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The imbalance between anti- and pro-inflammation often occurs in patients with sepsis. And continuous such imbalance could lead to immunoparalysis, which is characterized by loss of delayed type hypersensitivity, failure of primary infections eradication, and a predisposition of secondary nosocomial infections development. However, in which phase of sepsis does immunoparalysis occur is still unknown. So this study aims to tentatively understand this problem by checking monocytes/macrophages' antigen presentation and cytokine secretion,and by checking monocytes/macrophages' expression of Tim-3 (the T cell transmembrane, immunoglobulin, and mucin-3), which is an inhibitory regulatory molecule, in sepsis patients' peripheral blood mononuclear cells.

Registry
clinicaltrials.gov
Start Date
August 2012
End Date
July 2015
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Chinese PLA General Hospital
Responsible Party
Principal Investigator
Principal Investigator

Jia Li

Medical doctor of Department of Respirtory Disease

Chinese PLA General Hospital

Eligibility Criteria

Inclusion Criteria

  • age over 18 years old;
  • Fulfilled at least two criteria of systemic inflammatory response syndrome (a) core temperature higher than 38 ℃ or lower than 36 ℃ (b)respiratory rate above 20/min, or carbon dioxide partial pressure below 32 mmHg (c) pulse rate above 90/min, and (d) white blood cell count greater than 12,000/μl or lower than \< 4,000/μl or less than 10% of bands.
  • Clinically suspected infection;

Exclusion Criteria

  • were under 18 years of age;
  • were refused by the patients or his/her familiality;
  • were suffering from acquired immunodeficiency syndrome,viral hepatitis,autoimmune diseases and hematology;
  • use medicine which can affect immune system,such as Glucocorticoid and Immunosuppressant
  • died within 24h after being taken into the ICU, or refused to get involved in the study, or gave up treatment during the period of observation

Outcomes

Primary Outcomes

systemic inflammatory response to infection with organ dysfunction, hypoperfusion, or hypotension

Time Frame: within 24 hours after enter experimental group

Study Sites (1)

Loading locations...

Similar Trials